Literature DB >> 1452363

Frequency of antigen-specific B cells during experimental ocular Chlamydia trachomatis infection.

S Pal1, H R Taylor, R B Huneke, R A Prendergast, J A Whittum-Hudson.   

Abstract

Chlamydia-specific antibody-secreting cells have been identified in conjunctiva and draining cervical lymph nodes by an ELISPOT assay in a cynomolgus monkey model of trachoma. These local sites contained numbers of chlamydia-specific B cells that were higher than those in distant inguinal lymph nodes and peripheral blood. The numbers of chlamydia-specific immunoglobulin G-secreting B cells observed were 5 to 57 per 10(6) cells in conjunctiva and 24 to 996 per 10(6) cells in cervical lymph nodes during conjunctival infection or after challenge of immune monkeys with the chlamydial 57-kDa heat shock protein (hsp60). These studies demonstrate a large chlamydia-specific B-cell component in the conjunctiva during ocular chlamydial infection. These results are similar to our findings for chlamydia-specific T-cell responses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1452363      PMCID: PMC258309          DOI: 10.1128/iai.60.12.5294-5297.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Antichlamydial specificity of conjunctival lymphocytes during experimental ocular infection.

Authors:  J A Whittum-Hudson; H R Taylor
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

2.  Changes in conjunctival lymphocyte populations induced by oral immunization with Chlamydia trachomatis.

Authors:  J A Whittum-Hudson; R A Prendergast; H R Taylor
Journal:  Curr Eye Res       Date:  1986-12       Impact factor: 2.424

3.  A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells.

Authors:  J D Sedgwick; P G Holt
Journal:  J Immunol Methods       Date:  1983-02-25       Impact factor: 2.303

Review 4.  Chlamydial infections.

Authors:  J Schachter; M Grossman
Journal:  Annu Rev Med       Date:  1981       Impact factor: 13.739

5.  An animal model for cicatrizing trachoma.

Authors:  H R Taylor; R A Prendergast; C R Dawson; J Schachter; A M Silverstein
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-09       Impact factor: 4.799

6.  An animal model of trachoma II. The importance of repeated reinfection.

Authors:  H R Taylor; S L Johnson; R A Prendergast; J Schachter; C R Dawson; A M Silverstein
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-10       Impact factor: 4.799

7.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

8.  Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein.

Authors:  R P Morrison; R J Belland; K Lyng; H D Caldwell
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

9.  High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis.

Authors:  R S Stephens; E A Wagar; G K Schoolnik
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  7 in total

1.  Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines.

Authors:  A B Hartman; L L Van de Verg; H H Collins; D B Tang; N O Bendiuk; D N Taylor; C J Powell
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

2.  Characterization of humoral immune responses to chlamydial HSP60, CPAF, and CT795 in inflammatory and severe trachoma.

Authors:  Troy Skwor; Ram Prasad Kandel; Sunniya Basravi; Aslam Khan; Bassant Sharma; Deborah Dean
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-12       Impact factor: 4.799

3.  ELISPOT assay for Chlamydia-specific, antibody-producing cells correlated with conventional complement fixation and microimmunofluorescence.

Authors:  H Daugharty; T O Messmer; B S Fields
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

4.  Characterization of B-cell responses to Chlamydia trachomatis antigens in humans with trachoma.

Authors:  S Ghaem-Maghami; R L Bailey; D C Mabey; P E Hay; O S Mahdi; H M Joof; H C Whittle; M E Ward; D J Lewis
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

5.  Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.

Authors:  S Pal; T J Fielder; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Mucosal and systemic immune responses to plasmid protein pgp3 in patients with genital and ocular Chlamydia trachomatis infection.

Authors:  S Ghaem-Maghami; G Ratti; M Ghaem-Maghami; M Comanducci; P E Hay; R L Bailey; D C W Mabey; H C Whittle; M E Ward; D J M Lewis
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

7.  Multiple Chlamydiaceae species in trachoma: implications for disease pathogenesis and control.

Authors:  Deborah Dean; Ram P Kandel; Him K Adhikari; Tracey Hessel
Journal:  PLoS Med       Date:  2008-01-03       Impact factor: 11.069

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.